Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,771,293
+$251,473 QoQ
Shares Held
7,039
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#2,062
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acropolis Investment Management, LLC holds $13,272,644 across 8 Drug Manufacturers - General names. ABBV ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
20,115 | $5,108,606 | |
| 2 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
7,039 | $1,771,293 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,768 | $1,769,188 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
17,771 | $1,023,965 | |
| 6 | AMGN |
Amgen Inc
|
1,487 | $538,472 | |
| 7 | PFE |
Pfizer Inc
|
18,379 | $442,566 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,606 | $202,902 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,771,293 | 7,039 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,519,820 | 6,988 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,608,112 | 7,038 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,615,686 | 6,978 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $599,923 | 3,232 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $732,062 | 3,494 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $603,469 | 3,396 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $843,634 | 4,272 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $665,154 | 3,878 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,013,022 | 5,563 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $862,408 | 5,565 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $818,488 | 5,491 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $447,168 | 3,319 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $367,507 | 2,306 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $374,288 | 2,316 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $315,661 | 2,352 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $375,548 | 2,452 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $392,144 | 2,419 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $327,532 | 2,419 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $250,689 | 2,324 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $261,775 | 2,324 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $251,503 | 2,324 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $229,193 | 2,139 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $204,873 | 2,339 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $193,709 | 1,973 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $152,151 | 1,997 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||